Category: Articles

Medical progress in recent decades has boosted the survival rate of children with cancer to 85%, but brain stem glioma remains a severe outlier. Dr. Jacques Grill, a French doctor, initially predicted a grim outcome for 6-year-old Lucas diagnosed with this rare and deadly tumor. However, an experimental treatment, randomly assigned to Lucas, led to the complete disappearance of the tumor, a unique case globally.

Officially known as diffuse intrinsic pontine glioma (DIPG), this rare cancer affects around 300 children annually in the United States and 100 in France. The standard two-year survival rate is only 10%, with radiotherapy as the primary treatment option.

Lucas participated in the Biomede trial in France, where he was randomly assigned the drug everolimus. Remarkably, he took the medication for over 5 years, resulting in the complete disappearance of his tumor. While seven other children from the trial survived, none experienced a complete tumor disappearance like Lucas. His case is now being considered a potential breakthrough for improving long-term outcomes in DIPG cases.

Lucas’s tumors had a rare genetic mutation, making them exceptionally responsive to everolimus. Biomedical researchers are now aiming to replicate this mutation in vitro, potentially paving the way for further trials to confirm its effectiveness. Although the journey toward an approved medication may take 10 to 15 years, scientists are optimistic about the accelerated pace of technological advancements.

Attending a loud concert often leaves attendees with a familiar sensation of ringing ears, with some experiencing temporary or even permanent hearing loss or significant alterations in how they perceive sound once the noise ceases. A team of scientists has now uncovered the biological underpinnings of this noise-induced hearing loss, revealing a promising pathway for prevention.

At the heart of their discovery, researchers at the University of Pittsburgh, USA, identified that loud noise exposure leads to cellular damage in the inner ear, linked to an overabundance of zinc—a mineral crucial for cellular health and auditory function.

Their groundbreaking research demonstrated that certain drugs, acting as molecular sponges, can absorb the excess zinc, offering a chance to either recover hearing lost to noise exposure or preemptively safeguard against hearing damage when administered prior to encountering loud sounds.

Professor Thanos Tzounopoulos of the Pittsburgh Hearing Research Center highlighted the severe impact of noise-induced hearing loss, stating, “Noise-induced hearing loss can be debilitating. Some people start hearing sounds that aren’t there, developing a condition called tinnitus, which severely affects a person’s quality of life.”

Preventing hearing loss is a challenging problem to tackle, due to our incomplete understanding of the biological mechanisms. This is a great step in addressing the widespread impairment that effects millions.

The study, which was featured in the Proceedings of the National Academy of Sciences, detailed their investigation into the inner ear cells of mice. They discovered that zinc levels in the inner ear surge following exposure to loud noise, leading to cellular damage and interference with normal communication between cells.

Mice treated with a compound designed to capture excess zinc showed a higher resistance to hearing loss and were shielded from the adverse effects of loud noise exposure.

This research not only proposes a potential solution to a pervasive issue but also sets the stage for the development of treatments and protective measures for individuals frequently exposed to loud environments, such as concertgoers and musicians.

With plans to further explore this treatment, the researchers aim to eventually introduce it as an accessible, over-the-counter preventative measure against hearing loss, marking a significant step forward in auditory health protection.